EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

R213G‐Mediated Redistribution of EC‐SOD Protects Against Sugen‐Hypoxia Pulmonary Hypertension in Mice

Daniel Colon Hidalgo iD, Caitlin V Lewis, Thi-Tina N Nguyen, Janelle N Posey iD, Samuel D Burciaga, Nathan Dee, Christina Sul, Julie Harral, David Irwin, Cassidy Delaney, Eva S Nozik

Pulmonary Circulation · 2026-04 · 16 (2)

DOI: 10.1002/pul2.70307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 24.04.2026. Verfasst von Daniel Colon Hidalgo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine University of Colorado Anschutz Medical Campus Aurora Colorado USA. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) is a progressive and life‐threatening disease characterized by pulmonary vascular remodeling that leads to elevated pulmonary artery pressures, and subsequent right ventricular dysfunction. Despite advances in understanding PH pathogenesis, treatment options remain limited, underscoring the need to define novel mechanisms that contribute to disease progression. Inflammation and oxidative stress are recognized drivers of pulmonary vascular injury, with extracellular superoxide dismutase (EC‐SOD or SOD3 ), a matrix‐bound antioxidant enzyme, playing a role in multiple lung and vascular pathologies. A common human single nucleotide polymorphism (rs1799895) in the SOD3 gene leads to an arginine to glycine amino acid substitution (R213G) and alters EC‐SOD localization by reducing its affinity for the extracellular matrix, resulting in increased circulating but decreased lung EC‐SOD content. Using a murine knock‐in model of the R213G variant, we have previously demonstrated exacerbated chronic hypoxia‐induced PH. In this study, we examined the impact of EC‐SOD redistribution due to the R213G SOD3 variant on the development of PH in the Sugen‐hypoxia (SuHx) model, a more severe model of PH. We hypothesized that R213G mice would also have exaggerated hemodynamic changes, vascular remodeling, and inflammatory changes in this model. However, while SuHx increased pulmonary artery pressure and vascular remodeling in wild‐type mice, the R213G variant unexpectedly attenuated SuHx‐induced PH. Following SuHx, the increase in pulmonary artery pressures was attenuated in R213G mice. Early immune profiling revealed that SuHx triggered significant neutrophil and interstitial macrophage infiltration in the lungs of wild‐type mice, which was markedly blunted in R213G mice. These findings suggest that the redistribution of EC‐SOD into the extracellular fluid, though it lowed lung EC‐SOD levels, attenuated early inflammatory responses and protected against the development of PH in SuHx. This work highlights a novel, compartment‐specific role for EC‐SOD in modulating immune‐driven mechanisms of PH and may inform future therapeutic strategies targeting oxidative stress and inflammation in vascular disease.

Schlagwörter

Stichwörter der Autor:innen

Sugen‐hypoxiaextracellular superoxide dismutase (EC‐SOD)oxidative stress

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine University of Colorado Anschutz Medical Campus Aurora Colorado USA.
  • Departments of Pediatrics and Medicine, Cardiovascular Pulmonary Research Group University of Colorado Anschutz Medical Campus Aurora Colorado USA.
  • Department of Pediatrics, Division of Critical Care University of Colorado Anschutz Medical Campus Aurora Colorado USA.
  • Department of Pediatrics, Division of Neonatology University of Colorado Anschutz Medical Campus Aurora Colorado USA.

ORCID-Profile: Daniel Colon Hidalgo, Janelle N Posey

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Colon Hidalgo, D., Lewis, C. V., Nguyen, T. N., Posey, J. N., Burciaga, S. D., Dee, N., Sul, C., Harral, J., Irwin, D., Delaney, C., & Nozik, E. S. (2026). R213G‐Mediated Redistribution of EC‐SOD Protects Against Sugen‐Hypoxia Pulmonary Hypertension in Mice. Pulmonary Circulation, 16(2). https://doi.org/10.1002/pul2.70307

Vancouver

Colon Hidalgo D, Lewis CV, Nguyen TN, Posey JN, Burciaga SD, Dee N, et al. R213G‐Mediated Redistribution of EC‐SOD Protects Against Sugen‐Hypoxia Pulmonary Hypertension in Mice. Pulmonary Circulation. 2026;16(2). doi:10.1002/pul2.70307

BibTeX
@article{ColonHidalgo2026,
  author = {Colon Hidalgo, Daniel and Lewis, Caitlin V and Nguyen, Thi-Tina N and Posey, Janelle N and Burciaga, Samuel D and Dee, Nathan and Sul, Christina and Harral, Julie and Irwin, David and Delaney, Cassidy and Nozik, Eva S},
  title = {R213G‐Mediated Redistribution of EC‐SOD Protects Against Sugen‐Hypoxia Pulmonary Hypertension in Mice},
  journal = {Pulmonary Circulation},
  year = {2026},
  volume = {16},
  number = {2},
  doi = {10.1002/pul2.70307}
}
Kostenlos starten →